Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 629


Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells.

Park S, Li C, Zhao H, Darzynkiewicz Z, Xu D.

Oncotarget. 2016 Jan 9. doi: 10.18632/oncotarget.6866. [Epub ahead of print]


Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells.

Hanly EK, Tuli NY, Bednarczyk RB, Suriano R, Geliebter J, Moscatello AL, Darzynkiewicz Z, Tiwari RK.

Oncotarget. 2015 Dec 28. doi: 10.18632/oncotarget.6779. [Epub ahead of print]


Rapid and simple detection of gero-suppressive agents.

Darzynkiewicz Z.

Oncotarget. 2015 Sep 15;6(27):23050-1. No abstract available.


mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib.

Hanly EK, Bednarczyk RB, Tuli NY, Moscatello AL, Halicka HD, Li J, Geliebter J, Darzynkiewicz Z, Tiwari RK.

Oncotarget. 2015 Nov 24;6(37):39702-13. doi: 10.18632/oncotarget.4052.


Effect of different N7 substitution of dinucleotide cap analogs on the hydrolytic susceptibility towards scavenger decapping enzymes (DcpS).

Piecyk K, Darzynkiewicz ZM, Jankowska-Anyszka M, Ferenc-Mrozek A, Stepinski J, Darzynkiewicz E, Bojarska E.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):89-93. doi: 10.1016/j.bbrc.2015.06.001. Epub 2015 Jun 4.


Biguanides and targeted anti-cancer treatments.

Hanly EK, Darzynkiewicz Z, Tiwari RK.

Genes Cancer. 2015 Mar;6(3-4):82-3. No abstract available.


Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells.

Zhao H, Zhang S, Xu D, Lee MY, Zhang Z, Lee EY, Darzynkiewicz Z.

Cell Cycle. 2014;13(22):3529-40. doi: 10.4161/15384101.2014.958910.


Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Kowalska J, Wypijewska del Nogal A, Darzynkiewicz ZM, Buck J, Nicola C, Kuhn AN, Lukaszewicz M, Zuberek J, Strenkowska M, Ziemniak M, Maciejczyk M, Bojarska E, Rhoads RE, Darzynkiewicz E, Sahin U, Jemielity J.

Nucleic Acids Res. 2014;42(16):10245-64. doi: 10.1093/nar/gku757. Epub 2014 Aug 22.


Attenuation of replication stress-induced premature cellular senescence to assess anti-aging modalities.

Zhao H, Darzynkiewicz Z.

Curr Protoc Cytom. 2014 Jul 1;69:9.47.1-9.47.10. doi: 10.1002/0471142956.cy0947s69.


Different rates of DNA replication at early versus late S-phase sections: multiscale modeling of stochastic events related to DNA content/EdU (5-ethynyl-2'deoxyuridine) incorporation distributions.

Li B, Zhao H, Rybak P, Dobrucki JW, Darzynkiewicz Z, Kimmel M.

Cytometry A. 2014 Sep;85(9):785-97. doi: 10.1002/cyto.a.22484. Epub 2014 Jun 3.


Cytotoxic activity of the amphibian ribonucleases onconase and r-amphinase on tumor cells from B cell lymphoproliferative disorders.

Smolewski P, Witkowska M, Zwolinska M, Cebula-Obrzut B, Majchrzak A, Jeske A, Darzynkiewicz Z, Ardelt W, Ardelt B, Robak T.

Int J Oncol. 2014 Jul;45(1):419-25. doi: 10.3892/ijo.2014.2405. Epub 2014 Apr 28.


In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.

Darzynkiewicz Z, Zhao H, Halicka HD, Li J, Lee YS, Hsieh TC, Wu JM.

Cytometry A. 2014 May;85(5):386-99. doi: 10.1002/cyto.a.22452. Epub 2014 Feb 22. Review.


Disruption of mutated BRAF signaling modulates thyroid cancer phenotype.

Hanly EK, Rajoria S, Darzynkiewicz Z, Zhao H, Suriano R, Tuli N, George AL, Bednarczyk R, Shin EJ, Geliebter J, Tiwari RK.

BMC Res Notes. 2014 Mar 28;7:187. doi: 10.1186/1756-0500-7-187.


Multivariate analysis of apoptotic markers versus cell cycle phase in living human cancer cells by microfluidic cytometry.

Akagi J, Skommer J, Matuszek A, Takeda K, Fujimura Y, Khoshmanesh K, Kalantar-Zadeh K, Mitchell A, Errington R, Smith PJ, Darzynkiewicz Z, Wlodkowic D.

Proc SPIE Int Soc Opt Eng. 2013 Mar 9;8615. doi: 10.1117/12.2001474.


In vitro cytotoxicity of ranpirnase (onconase) in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line.

Majchrzak A, Witkowska M, Mędra A, Zwolińska M, Bogusz J, Cebula-Obrzut B, Darzynkiewicz Z, Robak T, Smolewski P.

Postepy Hig Med Dosw (Online). 2013 Dec 2;67:1166-72.


NFAT5 is protective against ischemic acute kidney injury.

Hao S, Bellner L, Zhao H, Ratliff BB, Darzynkiewicz Z, Vio CP, Ferreri NR.

Hypertension. 2014 Mar;63(3):e46-52. doi: 10.1161/HYPERTENSIONAHA.113.02476. Epub 2013 Dec 30.


The tail that wags the dog: p12, the smallest subunit of DNA polymerase δ, is degraded by ubiquitin ligases in response to DNA damage and during cell cycle progression.

Lee MY, Zhang S, Lin SH, Wang X, Darzynkiewicz Z, Zhang Z, Lee EY.

Cell Cycle. 2014;13(1):23-31. doi: 10.4161/cc.27407. Epub 2013 Dec 3.


Myron Melamed, 1927-2013.

Darzynkiewicz Z, Kamentsky L, Holden E.

Cytometry A. 2013 Dec;83(12):1047-50. doi: 10.1002/cyto.a.22413. No abstract available.


DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5-ethynyl-2'-deoxyuridine incorporated into DNA.

Zhao H, Halicka HD, Li J, Biela E, Berniak K, Dobrucki J, Darzynkiewicz Z.

Cytometry A. 2013 Nov;83(11):979-88. doi: 10.1002/cyto.a.22396. Epub 2013 Sep 30.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk